$BioVie(BIVI.US)$BioVie Awarded up to $13.1 Million in Funding From U.S. Department of Defense to Evaluate Bezisterim (Ne3107) for the Treatment of Long Covid
$BioVie(BIVI.US)$ NEWS BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary BioVie Inc. (Nasdaq: BIVI) announced the approval of the non-proprietary name 'bezisterim' for NE3107, a potential treatment for neurological disorders. The company will present data at the 12th Annual Alzheimer's & Parkinson's Drug Development S...
$BioVie(BIVI.US)$BIV201 Phase 3 is pending funds from “undisclosed yet partner” , partner is dragging their feet and not in a hurry to cut the check due economy , covid and ukraine bull. Especially if that undisclosed yet partner is looking to buy out Biovie , thus intrested to buy BIVI shares at cheap. The good news will be in “middle of summer 2024” or earlier , when partnership and BIV201 Phase 3 funding will be announced
$BioVie(BIVI.US)$BUG BIG news, there finished the second stage of testing(which worked) for a new drug that helps with Parkinson's and dementia, they have 1 more test and if it works they will go NUCLEAR!!! ☘️💪🔥😇🙏
BioVie's NE3107: A New Hope for Parkinson's and Alzheimer's Patients. In the realm of neurodegenerative disease research, significant strides are being made. One such stride is the development of BioVie Inc.'s drug NE3107, which has shown promising preliminary results in treating both motor and non-motor symptoms for Parkinson's patients. The data is set to be presented at the International Conference on Alzheimer'...
买跌不追涨 : 新冠病毒還沒結束啊
Trytosaveabit樓主 买跌不追涨: 不!他們上週剛發布了信息,供公司對其疫苗進行修改,以對抗今年的新/突變變體!格拉爾
买跌不追涨 Trytosaveabit樓主: 哎,沒完沒了了。其實如果這個病毒不再死人的話就當作感冒病毒好了
Trytosaveabit樓主 买跌不追涨: 如果選擇接受 MRNA 疫苗還是像感冒一樣治療?是的,我會像感冒一樣對待它!這是來自一個近三個月的人,直到我在 1 月 22 日實際上能夠呼吸一半正確的呼吸!嘿河
买跌不追涨 Trytosaveabit樓主: 啊,你還好吧?去進行治療了嗎?
查看更多評論...